Filter Results:
(291)
Show Results For
- All HBS Web
(291)
- News (118)
- Research (123)
- Events (1)
- Multimedia (3)
- Faculty Publications (44)
Show Results For
- All HBS Web
(291)
- News (118)
- Research (123)
- Events (1)
- Multimedia (3)
- Faculty Publications (44)
- Web
Social Enterprise - Faculty & Research
strategically respond to government signals regarding appropriate corporate activity. We integrate institutional theory and research on corporate political strategy to develop a political dependence model that explains (a) how different... View Details
- 08 May 2018
- First Look
First Look at New Research and Ideas, May 8, 2018
about the popularity of songs and romantic matches (Experiments 1B and 1C). Yet, researchers predicted the opposite result (Experiment 1D). Algorithm appreciation persisted when advice appeared jointly or separately (Experiment 2).... View Details
Keywords: Sean Silverthorne
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
news hook, although it may not be as obvious as, say, a breakthrough in cancer research. Remember the aforementioned research by Bazerman et al., which explained the unconscious biases that cause auditors to... View Details
- Web
Business & Environment - Faculty & Research
innovation, in the sense that research can be directed to either clean or dirty technologies. If dirty technologies are more advanced to start with, the potential transition to clean technology can be difficult both because clean View Details
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
the threshold for research and development (R&D) investment in an economically viable product. Further, the small size of patient populations for orphan drugs, together with the increasing prevalence of biologics among orphan drugs,... View Details
Keywords: Dina Gerdeman
- 07 Nov 2017
- First Look
New Research and Ideas: November 7, 2017
https://www.hbs.edu/faculty/Pages/item.aspx?num=53441 forthcoming Operations Research Letters Orienteering for Electioneering By: Kallenbach, Jonah, Robert Kleinberg, and Scott Duke Kominers Abstract—In this paper, we introduce a... View Details
Keywords: Carmen Nobel
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- 01 Dec 2014
- News
Research Brief: The Power of Could
Say you’re in a bind, a tough one. You’ve got cancer and your only hope is chemo—the problem is, it’s wildly expensive and you’re flat broke. Do you follow your moral compass, even if it means dying? Or do you leverage your knack for... View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
researchers to test and build new theories at a more granular level. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55151 forthcoming American Economic Review Beliefs about Gender By: Bordalo, Pedro, Katherine Baldiga... View Details
Keywords: Dina Gerdeman
- 12 Dec 2017
- First Look
New Research and Ideas, December 12, 2017
protagonist on the precipice of a great crisis: Shackleton marooned on an Antarctic ice floe; Lincoln on the verge of seeing the Union collapse; escaped slave Douglass facing possible capture; Bonhoeffer agonizing over how to counter absolute evil with faith; Carson... View Details
Keywords: Sean Silverthorne
- 16 Jul 2019
- News
The Making of a Movement
proceeds from research specific to sarcoma—the disease Jen fought—to all rare cancers. The significance of that selfless shift was seismic. By loosening the link between Cycle for Survival and their own circumstances, the Linns gave... View Details
- Web
Faculty & Researchers - Managing the Future of Work
Faculty & Researchers Faculty & Researchers Project Co-Chairs Joseph B. Fuller Professor of Management Practice Joseph Fuller is a Professor of Management Practice at the Harvard Business School, the... View Details
- 29 Aug 2017
- First Look
First Look at New Research and Ideas, August 29
people imagining imminent death. Study 1 revealed that blog posts of near-death patients with cancer and amyotrophic lateral sclerosis were more positive and less negative than the simulated blog posts of nonpatients—and also that the... View Details
Keywords: Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
therapies for a given disease and promised a number of efficiency improvements. They also used statistical techniques to allow more patients access to promising therapies. As such, they had the potential to fundamentally change the clinical View Details
Keywords: Sean Silverthorne
- 09 Jan 2018
- First Look
First Look at New Research and Ideas, January 9, 2018
type of entrepreneurial population studied (e.g., Main Street vs. those backed by venture capital) to identify interesting and irreducible parts of this heterogeneity, while also identifying places where we anticipate future large-scale View Details
Keywords: Sean Silverthorne
- 17 Aug 2011
- News
Breath of Life
Green: Participating in the stem-cell revolution. Courtesy David Green It was the kind of medical miracle that experts say will one day be commonplace. In June, an artificial trachea (windpipe), infused with a tracheal cancer patient’s... View Details
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- May–June 2018
- Article
Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations
By: Joel Goh, Mohsen Bayati, Stefanos A. Zenios, Sundeep Singh and David Moore
Cost-effectiveness studies of medical innovations often suffer from data inadequacy. When Markov chains are used as a modeling framework for such studies, this data inadequacy can manifest itself as imprecision in the elements of the transition matrix. In this paper,... View Details
Keywords: Markov Chains; Cost Effectiveness; Medical Innovations; Colorectal Cancer; Health Care and Treatment; Cost vs Benefits; Innovation and Invention; Mathematical Methods; Health Industry
Goh, Joel, Mohsen Bayati, Stefanos A. Zenios, Sundeep Singh, and David Moore. "Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations." Operations Research 66, no. 3 (May–June 2018): 697–715. (Winner, 2014 INFORMS Health Applications Society Pierskalla Award & Finalist, 2014 INFORMS George E. Nicholson student paper competition.)
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.